NO823717L - Fremgangsmaate ved fremstilling av nitroimidazolderivater - Google Patents
Fremgangsmaate ved fremstilling av nitroimidazolderivaterInfo
- Publication number
- NO823717L NO823717L NO823717A NO823717A NO823717L NO 823717 L NO823717 L NO 823717L NO 823717 A NO823717 A NO 823717A NO 823717 A NO823717 A NO 823717A NO 823717 L NO823717 L NO 823717L
- Authority
- NO
- Norway
- Prior art keywords
- acid
- vitamin
- acne
- nitroimidazole
- procedure
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 6
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 claims description 19
- 229930002330 retinoic acid Natural products 0.000 claims description 14
- 239000002253 acid Substances 0.000 claims description 8
- 230000000699 topical effect Effects 0.000 claims description 4
- 125000004432 carbon atom Chemical group C* 0.000 claims description 3
- 125000002883 imidazolyl group Chemical group 0.000 claims description 3
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 claims description 2
- 125000001931 aliphatic group Chemical group 0.000 claims description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 2
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims 3
- 230000000844 anti-bacterial effect Effects 0.000 claims 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims 1
- 206010000496 acne Diseases 0.000 description 16
- 208000002874 Acne Vulgaris Diseases 0.000 description 14
- 239000000203 mixture Substances 0.000 description 14
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 10
- VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 description 10
- 210000003491 skin Anatomy 0.000 description 9
- 229960000282 metronidazole Drugs 0.000 description 8
- 238000011282 treatment Methods 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 7
- 150000002148 esters Chemical class 0.000 description 7
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- LZCLXQDLBQLTDK-UHFFFAOYSA-N ethyl 2-hydroxypropanoate Chemical compound CCOC(=O)C(C)O LZCLXQDLBQLTDK-UHFFFAOYSA-N 0.000 description 6
- 150000004957 nitroimidazoles Chemical class 0.000 description 6
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 5
- YZEUHQHUFTYLPH-UHFFFAOYSA-N 2-nitroimidazole Chemical compound [O-][N+](=O)C1=NC=CN1 YZEUHQHUFTYLPH-UHFFFAOYSA-N 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 239000008194 pharmaceutical composition Substances 0.000 description 4
- 210000001732 sebaceous gland Anatomy 0.000 description 4
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 4
- 108090000371 Esterases Proteins 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 229940116333 ethyl lactate Drugs 0.000 description 3
- 230000001530 keratinolytic effect Effects 0.000 description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
- -1 vitamin A acid ester Chemical class 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- 150000007933 aliphatic carboxylic acids Chemical class 0.000 description 2
- 125000005907 alkyl ester group Chemical group 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 229940058965 antiprotozoal agent against amoebiasis and other protozoal diseases nitroimidazole derivative Drugs 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- OBBCSXFCDPPXOL-UHFFFAOYSA-N misonidazole Chemical compound COCC(O)CN1C=CN=C1[N+]([O-])=O OBBCSXFCDPPXOL-UHFFFAOYSA-N 0.000 description 2
- 229950010514 misonidazole Drugs 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 210000002374 sebum Anatomy 0.000 description 2
- 241001148471 unidentified anaerobic bacterium Species 0.000 description 2
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- OBWAFSRXIGEEKA-YCNIQYBTSA-N (2e,4e,6e,8e)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoyl chloride Chemical compound ClC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OBWAFSRXIGEEKA-YCNIQYBTSA-N 0.000 description 1
- UZFMOKQJFYMBGY-UHFFFAOYSA-N 4-hydroxy-TEMPO Chemical compound CC1(C)CC(O)CC(C)(C)N1[O] UZFMOKQJFYMBGY-UHFFFAOYSA-N 0.000 description 1
- 208000020154 Acnes Diseases 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- 241000186427 Cutibacterium acnes Species 0.000 description 1
- 102000016736 Cyclin Human genes 0.000 description 1
- 108050006400 Cyclin Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 229940124091 Keratolytic Drugs 0.000 description 1
- 206010033733 Papule Diseases 0.000 description 1
- 241000186429 Propionibacterium Species 0.000 description 1
- 206010037888 Rash pustular Diseases 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 230000003325 follicular Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000001329 hyperkeratotic effect Effects 0.000 description 1
- 239000003701 inert diluent Substances 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000003410 keratolytic agent Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000003883 ointment base Substances 0.000 description 1
- 229940127249 oral antibiotic Drugs 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 229940055019 propionibacterium acne Drugs 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 208000029561 pustule Diseases 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 150000004508 retinoic acid derivatives Chemical class 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 229940040944 tetracyclines Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- 229940005605 valeric acid Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/91—Nitro radicals
- C07D233/92—Nitro radicals attached in position 4 or 5
- C07D233/94—Nitro radicals attached in position 4 or 5 with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to other ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8112600A GB2097783B (en) | 1981-04-23 | 1981-04-23 | Imidazoles |
| EP82305740A EP0106926A1 (en) | 1981-04-23 | 1982-10-28 | Nitroimidazole compounds and compositions useful in the treatment of acne |
| JP57191913A JPS5982371A (ja) | 1981-04-23 | 1982-11-02 | ニトロイミダゾ−ル化合物と組成物及び製造方法 |
| AU90115/82A AU9011582A (en) | 1981-04-23 | 1982-11-03 | Nitroimidazole derivatives |
| DK488582A DK488582A (da) | 1981-04-23 | 1982-11-03 | Nitroimidazolderivat, fremgangsmaade til dets fremstilling og anvendelse heraf i kosmetiske praeparater mod acne |
| NO823717A NO823717L (no) | 1981-04-23 | 1982-11-08 | Fremgangsmaate ved fremstilling av nitroimidazolderivater |
| ES517204A ES517204A0 (es) | 1981-04-23 | 1982-11-08 | Procedimiento para preparar un derivado de nitroimidazol. |
| FI823817A FI823817L (fi) | 1981-04-23 | 1982-11-08 | Nitroimidazolfoereningar och kompositioner anvaendbara vid behandling av acne |
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8112600A GB2097783B (en) | 1981-04-23 | 1981-04-23 | Imidazoles |
| EP82305740A EP0106926A1 (en) | 1981-04-23 | 1982-10-28 | Nitroimidazole compounds and compositions useful in the treatment of acne |
| JP57191913A JPS5982371A (ja) | 1981-04-23 | 1982-11-02 | ニトロイミダゾ−ル化合物と組成物及び製造方法 |
| AU90115/82A AU9011582A (en) | 1981-04-23 | 1982-11-03 | Nitroimidazole derivatives |
| DK488582A DK488582A (da) | 1981-04-23 | 1982-11-03 | Nitroimidazolderivat, fremgangsmaade til dets fremstilling og anvendelse heraf i kosmetiske praeparater mod acne |
| NO823717A NO823717L (no) | 1981-04-23 | 1982-11-08 | Fremgangsmaate ved fremstilling av nitroimidazolderivater |
| ES517204A ES517204A0 (es) | 1981-04-23 | 1982-11-08 | Procedimiento para preparar un derivado de nitroimidazol. |
| FI823817A FI823817L (fi) | 1981-04-23 | 1982-11-08 | Nitroimidazolfoereningar och kompositioner anvaendbara vid behandling av acne |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO823717L true NO823717L (no) | 1984-05-09 |
Family
ID=27570114
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO823717A NO823717L (no) | 1981-04-23 | 1982-11-08 | Fremgangsmaate ved fremstilling av nitroimidazolderivater |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP0106926A1 (es) |
| JP (1) | JPS5982371A (es) |
| AU (1) | AU9011582A (es) |
| DK (1) | DK488582A (es) |
| ES (1) | ES517204A0 (es) |
| FI (1) | FI823817L (es) |
| GB (1) | GB2097783B (es) |
| NO (1) | NO823717L (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2558058B1 (fr) * | 1984-01-18 | 1987-03-20 | Pf Medicament | Compositions dermatologiques a usage topique externe, a base de metronidazole utiles pour le traitement de l'acne |
| JPS6322510A (ja) * | 1986-07-14 | 1988-01-30 | Shiseido Co Ltd | 皮膚外用剤 |
| US4885311A (en) * | 1987-06-29 | 1989-12-05 | Molecular Design International | Topical transretinoids for treatment of acne and skin diseases |
| GB8910069D0 (en) * | 1989-05-03 | 1989-06-21 | Janssen Pharmaceutica Nv | Method of topically treating acne vulgaris |
| US5559149A (en) | 1990-01-29 | 1996-09-24 | Johnson & Johnson Consumer Products, Inc. | Skin care compositions containing retinoids |
| GR1002207B (en) * | 1992-08-06 | 1996-03-27 | Johnson & Johnson Consumer | Skin care compositions containing imidazoles. |
| GB2313058B (en) * | 1993-03-29 | 1998-01-21 | Bioglan Ireland | Pharmaceutically useful thiopheneyl derivatives |
| US5536740A (en) * | 1995-06-01 | 1996-07-16 | Elizabeth Arden Company, Division Of Conopco, Inc. | Skin care compositions containing dimethyl imidazolidinone and retinol or retinyl ester |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB901060A (en) * | 1960-07-01 | 1962-07-11 | Rhone Poulenc Sa | Improvements in or relating to imidazole derivatives |
| FR1393963A (fr) * | 1961-07-07 | 1965-04-02 | Rhone Poulenc Sa | Nouveau dérivé de l'imidazole et sa préparation |
| US3803165A (en) * | 1972-08-14 | 1974-04-09 | Hoffmann La Roche | N-(2-(2-nitro-1-imidazolyl)ethyl)-2',2',2'-trichloroethyl carbamate |
-
1981
- 1981-04-23 GB GB8112600A patent/GB2097783B/en not_active Expired
-
1982
- 1982-10-28 EP EP82305740A patent/EP0106926A1/en not_active Withdrawn
- 1982-11-02 JP JP57191913A patent/JPS5982371A/ja active Pending
- 1982-11-03 DK DK488582A patent/DK488582A/da not_active Application Discontinuation
- 1982-11-03 AU AU90115/82A patent/AU9011582A/en not_active Abandoned
- 1982-11-08 NO NO823717A patent/NO823717L/no unknown
- 1982-11-08 ES ES517204A patent/ES517204A0/es active Granted
- 1982-11-08 FI FI823817A patent/FI823817L/fi not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| FI823817A0 (fi) | 1982-11-08 |
| GB2097783B (en) | 1984-12-12 |
| AU9011582A (en) | 1984-05-10 |
| EP0106926A1 (en) | 1984-05-02 |
| ES8404679A1 (es) | 1984-05-01 |
| JPS5982371A (ja) | 1984-05-12 |
| FI823817L (fi) | 1984-05-09 |
| ES517204A0 (es) | 1984-05-01 |
| DK488582A (da) | 1984-05-04 |
| GB2097783A (en) | 1982-11-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2275867A1 (en) | Method for treatment of dermatological disorders | |
| US5086060A (en) | Compound and method for treating skin for acne or psoriasis | |
| NO311066B1 (no) | Stabile, topiske retinoidpreparater og anvendelse derav | |
| GB2174906A (en) | Topical compositions containing salicylic acid derivatives | |
| CA2453823A1 (en) | Dermal therapy using phosphate derivatives of electron transfer agents | |
| NO823717L (no) | Fremgangsmaate ved fremstilling av nitroimidazolderivater | |
| US4132781A (en) | Method for treatment of acne | |
| FI96201B (fi) | Menetelmä uuden terapeuttisesti käyttökelpoisen retinoidin valmistamiseksi | |
| JPH0420427B2 (es) | ||
| FR2598420A1 (fr) | Nouveaux esters retinoiques d'antibiotiques, leur procede de preparation et compositions pharmaceutiques et cosmetiques les contenant | |
| GB2208149A (en) | Pharmaceutical and cosmetic compositions based on pyridones and antibacterial agents | |
| US3966967A (en) | Compositions and methods of treating psoriasis with vinyligs of desmethyl retinoic acid | |
| DE68919009T2 (de) | Verwendung von 5-Amino-salicylsäure für die Behandlung von Hautkrankheiten. | |
| MX2011006659A (es) | Acido graso poliinsaturado y ester de diol como agente anti-acne. | |
| US4857525A (en) | Quaternary ammonium retinoates, their use in cosmetics and in dermopharmacy | |
| ITMI942319A1 (it) | Nuovi derivati dell'acido kojico | |
| US4505930A (en) | Alpha-alkyl polyolefinic carboxylic acids and derivatives thereof useful in the treatment of psoriasis and allergic responses | |
| JP2002506035A (ja) | ヒドロキシカルボン酸の新規な送達 | |
| EP0751928B1 (en) | Dl- di- or tri-hydroxyphenylglycine alkyl esters for the treatment of inflammatory and allergic conditions | |
| AU605772B2 (en) | Topical prodrugs for treatment of acne and skin diseases | |
| JPH0749368B2 (ja) | 皮膚に適用するための水溶性ビタミンａの皮膚外用剤 | |
| JP3014401B2 (ja) | Ｄ―デソサミンのレチノイン酸エステル、その製法、ヒトまたは獣医用薬および化粧用組成物 | |
| JPS59134725A (ja) | 窒素含有安定剤を含む貯蔵安定な局所薬剤組成物 | |
| US8729312B2 (en) | Derivatives of novel peroxides, method of preparation thereof and use thereof in human medicine as well as in cosmetics for the treatment or prevention of acne | |
| NO168647B (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive retinsyreestere av lincomycin og clindamycin. |